Viking Rapidly Advancing Oral And Injectable VK2735 For Obesity

 
• By Joseph Haas
  
Viking is advancing injectable and oral versions of its GLP-1/GIP agonist. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business